Mounjaro®
Starting from £179.99/mo
Start journey Learn moreAt the 5mg dose, tirzepatide has a half-life of approximately five days — meaning it takes roughly five weeks for the medicine to leave your system completely after your last injection. That long half-life is what makes once-weekly dosing work: levels stay high enough between injections to keep appetite suppression consistent. As a prescription-only medicine, 5mg Mounjaro is prescribed only after a clinical assessment confirms it is appropriate for you. The answer below draws on the NHS medicines guidance for tirzepatide and the data reviewed by NICE when tirzepatide was appraised in 2024.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide's half-life was established through the clinical pharmacology studies that underpinned its MHRA authorisation and the SURMOUNT programme reviewed by NICE (NICE technology appraisal TA1026). A half-life of approximately five days means that five days after an injection, roughly half the dose has been broken down. After another five days, half of the remainder has gone. Work through four to five half-lives and you reach concentrations too small to be pharmacologically relevant, so the clearing process takes around four to five weeks in total.
At 5mg, that timeline is essentially the same as at other doses. What changes with dose is the peak concentration reached after each injection and, in turn, the magnitude of the appetite and blood-sugar effects. The half-life itself is a property of the molecule, not the strength of the pen. That is why the once-weekly schedule works across every dose from the 2.5mg starter through to 15mg: the dosing interval is designed around this elimination curve.
Steady state (the point at which concentrations stop climbing week-on-week and stabilise) is reached after about four to five weekly injections. If you have recently moved up from the starter dose, you can read more about the 2.5mg clearance timeline to see how the two phases compare.
The clinical implication most people care about is straightforward: if you stop 5mg Mounjaro today, you will not feel back to your pre-treatment baseline tomorrow, or even next week. Appetite suppression typically eases noticeably within the first two weeks as levels fall, but the medicine is still detectable (and still biologically active at diminishing concentrations) for a month or more. That gradual taper is actually considered clinically useful: it avoids an abrupt return of hunger in people who have been on treatment for some time.
For people thinking about stopping temporarily (for a surgical procedure, say, or a planned pregnancy) the NHS England clinical guidance advises discussing timing with your healthcare team well in advance, precisely because the washout period matters. Surgery requires particular care: your prescribing team and the anaesthetist should both know you are on tirzepatide, because slowed gastric emptying can persist for longer than the obvious pharmacological window.
If you are weighing up how long to stay on the 5mg dose before your next review, the page on how long to stay on 5mg Mounjaro covers the clinical rationale for the four-week titration step in more detail. The 5mg Mounjaro pen overview sets out what to expect from this particular dose in context.
Because the half-life is so long, a single missed injection does not reset the clock entirely. If you miss a dose and remember within four days, the NHS guidance indicates the injection can be given and the next one taken on the original day. If more than four days have passed, skip it and continue the usual weekly schedule. Your pen belongs in the fridge door alongside anything else you store at 2–8°C; if it has been left at room temperature, check the Patient Information Leaflet for the precise permitted window rather than relying on a rough rule of thumb.
A gap of more than four weeks (whether planned or unplanned) is a different matter. In that situation, the pharmacokinetics work in reverse: levels will have fallen substantially, and restarting at 5mg rather than jumping straight to a higher dose may be clinically appropriate to minimise side effects. That call sits with your prescriber, not a general guide. Our frequently asked questions cover what to do if you miss a scheduled injection, and the clinical team at nume includes GPhC-registered Independent Prescribers who review every consultation personally.
If you are thinking about the longer arc of treatment (how tirzepatide works across months rather than a single injection cycle) the broader Mounjaro treatment guide is a good place to start. For anyone on the starter dose who wants to understand the expected duration at that strength, our guide on how long you stay on 2.5mg Mounjaro explains what typically determines when it is time to move up. And for context on what private treatment costs before you go further, the Mounjaro cost page sets out what a transparent private prescription typically includes.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.